Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
2.170
-0.050 (-2.25%)
Dec 20, 2024, 4:00 PM EST - Market closed
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $59.69 million as of December 20, 2024. Its market cap has decreased by -39.79% in one year.
Market Cap
59.69M
Enterprise Value
41.09M
1-Year Change
-39.79%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has decreased from $65.74M to $59.69M, a decrease of -9.21%. That is a compound annual growth rate of -3.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 59.69M | -56.58% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 62.10M |
| PDS Biotechnology | 61.73M |
| IceCure Medical | 61.35M |
| WORK Medical Technology Group LTD | 61.29M |
| Annovis Bio | 60.29M |
| Vor Biopharma | 59.56M |
| Pheton Holdings | 59.42M |
| DBV Technologies | 59.31M |